Stock MSB MESOBLAST LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Mesoblast Limited

Equities

MSB

AU000000MSB8

Market Closed - Australian S.E.
Other stock markets
 02:10:21 2024-04-16 am EDT 		5-day change 1st Jan Change
0.77 AUD -7.23% Intraday chart for Mesoblast Limited -15.38% +148.39%
Apr. 01 ADRs End Higher; Connect Biopharma Climbs 26% DJ
Mar. 28 ADRs End Lower; NuCana Slides 15% DJ

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ADRs End Higher; Connect Biopharma Climbs 26%
DJ
ADRs End Lower; NuCana Slides 15%
DJ
Reddit Inc. (NYSE: RDDT) Surges, Uncovering Undervalued Opportunities: DYAI, INBS, MESO, VTAK
AQ
ADRs End Lower; Quhuo Drops 53%
DJ
FDA Says Mesoblast Trial Data Sufficient to Support BLA Submission
MT
Sector Update: Health Care Stocks Advance Late Afternoon
MT
Top Midday Gainers
MT
Sector Update: Health Care Stocks Steady Premarket Tuesday
MT
Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading
MT
Top Premarket Gainers
MT
Mesoblast Shares Jump After FDA Nod for Submission of Remestemcel-L Application
DJ
Mesoblast to Resubmit Application for Potential Pediatric Treatment of Graft Versus Host Disease; Shares Gain Pre-Bell
MT
United States Food & Drug Administration (FDA) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)
AQ
United States Food & Drug Administration Notifies Mesoblast Limited of Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease
CI
Mesoblast Limited(ASX:MSB) added to S&P/ASX Emerging Companies Index
CI
Mesoblast Raises AU$97 Million From Entitlement Offer, Institutional Placement
MT
Mesoblast Raises AU$97 Million for Phase Three Registration Trials
MT
Mesoblast Successfully Completes Placement and Accelerated Entitlement Offer
AQ
Sector Update: Health Care Stocks Softer Late Afternoon
MT
Sector Update: Health Care Stocks Decline in Afternoon Trading
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MSB Stock
  4. News Mesoblast Limited